Yijie Qu

Title: Yijie Qu: Innovator in Tumor-Infiltrating Lymphocyte Expansion

Introduction

Yijie Qu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunotherapy, particularly in the expansion of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by providing a more efficient way to produce TILs from small tumor samples.

Latest Patents

Yijie Qu holds a patent for "Methods for preparing tumor-infiltrating lymphocytes." This patent outlines methods for expanding TILs, which include co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to obtain an expanded TIL population. These methods can quickly produce a large number of TILs from a small tumor sample, showcasing Qu's innovative approach to cancer treatment.

Career Highlights

Yijie Qu is currently associated with Shanghai Abelzeta Ltd., where he continues to develop and refine his groundbreaking techniques. His work is pivotal in advancing the field of cancer immunotherapy, and he is recognized for his contributions to enhancing patient outcomes.

Collaborations

Yijie Qu collaborates with notable colleagues, including Jia Li and Jiyan Hou. Their combined expertise fosters a dynamic research environment that drives innovation in their field.

Conclusion

Yijie Qu's contributions to the expansion of tumor-infiltrating lymphocytes represent a significant advancement in cancer treatment methodologies. His innovative approaches and collaborations continue to pave the way for future breakthroughs in immunotherapy.